CEO of ProPhase Labs Ups Ad Spend in Response to ESPN On-Air Commentator
OTC Pharmaceutical Company Supports Stephen A. Smith's message; it's all about
DOYLESTOWN, Pa., May 28, 2014
DOYLESTOWN, Pa., May 28, 2014 /PRNewswire/ -- ProPhase Labs, Inc.(NASDAQ:
PRPH) today announced their support of ESPN's First Take host, Stephen A.
Smith by directing its ad agency to increase advertising of its products on
both ESPN and ESPN2.
In response to Stephen A. Smith's speech on Friday, May 23rd regarding race,
role models and the American Dream, Ted Karkus, ProPhase Labs' Chairman and
CEO, has decided to increase the ad spend in an effort to support the
commentators overall, insightful message to America's youth.
"The speech that Stephen A. Smith gave on Friday was not only a motivating
one, but provides guidance for all youth in our country," says Ted Karkus.
"Usually you hear about sponsors 'pulling the plug' when a commentator says
something inappropriate. In this case, I thought to do the opposite, i.e.
increase our ad spend to support a speech that literally brought tears to my
eyes. Being a CEO of a nationally recognized brand, I understand the obstacles
and the hard work it takes to achieve one's dreams. While Stephen's speech
primarily targeted underprivileged minorities, it was truly a speech that
transcended race. It was a message for the youth of America to work hard,
become educated, show respect for others and present yourself appropriately so
that success can become a reality as opposed to the one out of a billion
possibility of becoming the next Lebron or Jay Z.My wife taped the speech
and the first thing I did was replay it for my children. I am proud to be an
advertiser on ESPN and ESPN2 and look forward to flourishing my relationship
with the network and its personalities."
ProPhase Labs is an OTC pharmaceutical company based in Doylestown, PA. and
has been advertising with ESPN for the past 3 years. For more information on
ProPhase Labs and Ted Karkus, please visit ProPhaseLabs.com.
About ProPhase Labs
ProPhase Labs is a diversified natural health medical science company. It is a
leading marketer of the Cold-EEZE^® Cold Remedy brand as well as other cold
relief products. Cold-EEZE^® Cold Remedy zinc gluconate lozenges are
clinically proven to significantly reduce the duration of the common cold.
Cold-EEZE^® Cold Remedy customers include leading national chain, regional,
specialty and local retail stores. ProPhase Labs has several wholly owned
subsidiaries including a manufacturing unit, which consists of an FDA
registered facility to manufacture Cold-EEZE^® Cold Remedy lozenges and
fulfill other contract manufacturing opportunities. ProPhase also owns 50% of
Phusion Laboratories, LLC ("Phusion"). Phusion licenses a revolutionary
proprietary technology that has the potential to improve the delivery and/or
efficacy of many active ingredients or compounds. Phusion will formulate and
test products to exploit market opportunities within ProPhase's robust
over-the-counter distribution channels. For more information visit us at
SOURCE ProPhase Labs, Inc.
Contact: Laura Maxey, Lmaxey@5wpr.com, 646.452.6400
Press spacebar to pause and continue. Press esc to stop.